Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sen. Cassidy Suggests Importing Generics From EU To Pressure US Prices

Executive Summary

Idea may require tweaking existing agreements between FDA and EMA, but is another twist on drug importation, a concept that FDA opposes.


Related Content

Democrats’ Drug Pricing Bills Echo Trump Ideas But Broad Republican Support Unlikely
Gottlieb: Real Risk Of Congressional Action If Anti-Competitive Actions Continue
Brand 'Evergreening' Piques FDA Interest, But Solutions Remain Elusive
Drug Pricing: Could Expedited Review Of Competing Brands Create The Desired Pressure?
FDA Exploring Whether Public Shaming Can Stop REMS Abuses
User Fee Bill Or Drug Pricing Bill? House Members Makes Both Cases
Drug Pricing Hearing In Senate Postponed, Handing Innovators Another Victory
FDA Drug Pricing Policy Offers Short-Term PR Gain, More Long-Term Actual Benefit
Drug Importation Blocked But Not Forgotten As User Fee Bill Clears Senate Cmte
EU, US Finally Agree On Mutual Recognition Of GMP Inspections





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts